Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Atrial Fibrillation

October 25, 2016 — A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE compa ...

Home October 25, 2016
Home
Blog

The 2016 Nobel Prize in chemistry was recently awarded to three scientists who developed miniaturized machines that are ...

Home October 07, 2016
Home
News | Peripheral Artery Disease (PAD)

October 7, 2016 — Mercator MedSystems recently announced that 13-month data from the DANCE trial was presented during a ...

Home October 07, 2016
Home
News | Pharmaceuticals

September 26, 2016 — Nearly 2 out of 5 people with diabetes who could benefit from statin therapy to lower their risk of ...

Home September 26, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

September 1, 2016 — First outcome results from the GLORIA-AF Registry show that treatment with Pradaxa (dabigatran ...

Home September 01, 2016
Home
News | Hemostasis Management

August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to stopp ...

Home August 24, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

August 18, 2016 — Researchers at the Peter Munk Cardiac Centre, Toronto, and at Mayo Clinic are leading the Tailored ...

Home August 18, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

August 16, 2016 — Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood ...

Home August 16, 2016
Home
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC
Feature | Dave Fornell

 


August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional Cardiology ...

Home August 05, 2016
Home
Watchman, left atrial appendage closure, LAA occluder
Feature | Left Atrial Appendage (LAA) Occluders | Dave Fornell

Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...

Home August 01, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

July 26, 2016 — Hematology researchers at The Children’s Hospital of Philadelphia (CHOP) have developed a novel ...

Home July 26, 2016
Home
Technology | Antiplatelet and Anticoagulation Therapies

July 14, 2016 — BBMK Technologies recently announced the launch of ClotMD, a cloud-based application and mobile solution ...

Home July 14, 2016
Home
News | Blood Testing

July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will be ...

Home July 12, 2016
Home
pros and cons of new anticoagulation therapies, anticoagulants, dabigatran, Pradaxa, novel oral anticoagulants, NOACs, rivaroxaban, Xarelto, apixaban, Eliquis
Feature | Antiplatelet and Anticoagulation Therapies | Heidi Olson, Pharm.D

With the recent introduction of several novel oral anticoagulants (NOACs) on the U.S. market that have been billed by ...

Home July 26, 2016
Home
News | Heart Failure

June 30, 2016 — Researchers at Thomas Jefferson University have discovered how to enhance the effectiveness of beta ...

Home June 30, 2016
Home
Subscribe Now